| Literature DB >> 31414703 |
Qiaoqiao Teng1,2, Ping Siang Ng1, Jia Nuo Leung1, Han Vinh Huynh1.
Abstract
The suitability and acEntities:
Keywords: donor strength; electronic parameters; palladium; pnictogens; substituent effects
Year: 2019 PMID: 31414703 PMCID: PMC6900057 DOI: 10.1002/chem.201902795
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236
Figure 1Selected experimental electronic parameters.
Synthesis of trans‐[PdBr2(Pr2‐bimy)(Py‐R)] complexes 2–27, in which Py‐R=meta or para‐substituted pyridines, and their characteristic 1H NMR signals [ppm], HEP values [ppm],[a] and Hammett σ‐constants in CDCl3.
|
| ||||
|---|---|---|---|---|
|
R‐group |
δNCH |
δPyH2,6 |
HEP |
|
|
3‐CN ( |
6.25 |
9.53, 9.43 |
157.33 |
0.56 |
|
3‐NO2 ( |
6.28 |
10.10, 9.55 |
157.38 |
0.71 |
|
3‐CHO ( |
6.31 |
9.67, 9.43 |
158.54 |
0.35 |
|
3‐Br ( |
6.29 |
9.26, 9.11 |
158.63 |
0.39 |
|
3‐I ( |
6.29 |
9.36, 9.12 |
158.68 |
0.35 |
|
3‐Cl ( |
6.30 |
9.18, 9.07 |
158.72 |
0.37 |
|
3‐F ( |
6.30 |
9.12, 9.02 |
158.73 |
0.34 |
|
3‐CO2H ( |
6.33 |
9.81, 9.37 |
159.04 |
0.37 |
|
3‐OH ( |
6.32 |
8.63, 8.54 |
159.60 |
0.12 |
|
3‐Ph ( |
6.37 |
9.39, 9.12 |
159.80 |
0.06 |
|
3‐Et ( |
6.35 |
8.94, 8.92 |
160.33 |
−0.07 |
|
3‐Me ( |
6.34 |
8.91, 8.89 |
160.41 |
−0.07 |
|
3‐NH2 ( |
6.33 |
8.51, 8.44 |
160.47 |
−0.16 |
|
4‐CN ( |
6.25 |
9.42 |
157.79 |
0.66 |
|
4‐CF3 ( |
6.29 |
9.40 |
158.38 |
0.54 |
|
4‐CHO ( |
6.30 |
9.43 |
158.76 |
0.42 |
|
4‐Cl ( |
6.29 |
9.08 |
158.98 |
0.23 |
|
4‐CO2H ( |
6.31 |
9.36 |
159.00 |
0.45 |
|
4‐Br ( |
6.29 |
8.94 |
159.03 |
0.23 |
|
4‐I ( |
6.28 |
8.79 |
159.21 |
0.18 |
|
4‐Ph ( |
6.38 |
9.16 |
160.16 |
−0.01 |
|
4‐OMe ( |
6.33 |
8.92 |
160.39 |
−0.27 |
|
4‐Me ( |
6.33 |
8.93 |
160.43 |
−0.17 |
|
4‐Et ( |
6.34 |
8.96 |
160.58 |
−0.15 |
|
4‐NH2 ( |
6.34 |
8.61 |
161.35 |
−0.66 |
|
4‐NMe2 ( |
6.36 |
8.61 |
161.97 |
−0.83 |
[a] HEP values are given with the second decimal in subscript for comparison. Detailed discussion on standard deviations of HEP can be found in References [5], [7] and [8].
Selected NMR spectroscopic data of complexes 32–34 and trans‐36–39 measured in CDCl3.
|
Complex |
Ligand |
1HMe [ppm] |
HEP [ppm] |
2
|
|---|---|---|---|---|
|
|
TBD |
1.74 |
165.74 |
– |
|
|
DBU |
1.77 |
166.32 |
– |
|
|
NEt3 |
1.74 |
157.96 |
– |
|
|
P(O |
1.77 |
175.25 |
287.1 |
|
|
P(OPh)3 |
1.51 |
171.65 |
289.8 |
|
|
P(O‐2,4‐ |
1.59 |
171.48 |
289.6 |
|
|
AsPh3 |
1.79 |
169.17 |
– |
Figure 2Graphs and equations for the regressions of (i) HEP vs. σ m Hammett constants (upper) and (ii) HEP vs. σ p Hammett constants (lower).
Figure 3Determination of the Hammett constant and HEP for the carboxylic acid substituent.
Scheme 1Synthesis of HEP probes with different alkali pyridinecarboxylate ligands.
Figure 4Regression graphs and equation of HEP (meta) vs. HEP (para).
Selected NMR spectroscopic data of complexes cis‐35–37, cis‐39 and cis‐40 measured in CDCl3.
|
Complex |
Ligand |
1HMe [ppm] |
HEP [ppm] |
2
|
|---|---|---|---|---|
|
|
P(OMe)3 |
1.74, 1.66 |
170.79 |
21.4 |
|
|
P(O |
1.71, 1.69 |
171.98 |
22.9 |
|
|
P(OPh)3 |
1.57, 1.14 |
169.27 |
22.9 |
|
|
AsPh3 |
1.66, 0.89 |
169.34 |
– |
|
|
SbPh3 |
1.66, 1.04 |
167.46 |
– |
Figure 5The donor strengths of selected organometallic and Werner‐type ligands on the HEP scale.
Figure 6Molecular structures of 32, cis‐35⋅CH2Cl2, cis‐36⋅CHCl3, cis‐37⋅2CHCl3, cis‐39, cis‐40, 42 and 43⋅CHCl3 showing 50 % probability ellipsoids; hydrogen atoms and solvent molecules are omitted for clarity. Selected bond length [Å] and bond angles [°]: 32, Pd1−C1 1.967(4), Pd1−Br1 2.4380(7), Pd1−Br2 2.4341(7), Pd1−N3 2.075(4); C1‐Pd1‐Br1 86.3(1), C1‐Pd1‐Br2 89.2(1), Br1‐Pd1‐N3 93.4(1), Br2‐Pd1‐N3 91.2(1); PdCBr2N/NHC dihedral angle θ 88.1°. cis‐35, Pd1−C1 1.980(7), Pd1−Br1 2.4914(9), Pd1−Br2 2.472(1), Pd1−P1 2.204(2); C1‐Pd1‐Br1 84.8(2), C1‐Pd1‐P1 89.7(2), Br1‐Pd1‐Br2 94.21(3), Br2‐Pd1‐P1 91.30(6); θ 89.6°. cis‐36, Pd1−C1 1.988(3), Pd1−Br1 2.4853(4), Pd1−Br2 2.4779(4), Pd1−P1 2.2133(8); C1‐Pd1‐Br2 85.90(8), C1‐Pd1‐P1 90.41(8), Br1‐Pd1‐Br2 92.22(2), Br1‐Pd1‐P1 91.33(2); θ 83.8°. cis‐37, Pd1−C1 1.992(4), Pd1−Br1 2.4751(5), Pd1−Br2 2.4767(5), Pd1−P1 2.204(1); C1‐Pd1‐Br1 88.1(1), C1‐Pd1‐P1 90.4(1), Br1‐Pd1‐Br2 94.64(2), Br2‐Pd1‐P1 86.88(3); θ 82.8°. cis‐39, Pd1−C1 1.970(2), Pd1−Br1 2.4818(3), Pd1−Br2 2.4624(3), Pd1−As1 2.3568(3); C1‐Pd1‐Br2 85.44(6), C1‐Pd1‐As1 90.40(6), Br1‐Pd1‐Br2 93.92(1), Br1‐Pd1‐As1 90.09(1); θ 88.4°. cis‐40, Pd1−C1 1.971(3), Pd1−Br1 2.4699(4), Pd1−Br2 2.4771(4), Pd1−Sb1 2.4967(3); C1‐Pd1‐Br1 86.44(9), C1‐Pd1‐Sb1 95.66(9), Br1‐Pd1‐Br2 95.55(1), Br2‐Pd1‐Sb1 82.49(1); θ 84.2°. 42, Pd1−C1 1.969(3), Pd1−Br1 2.4286(4), Pd1−Br2 2.4342(4), Pd1−S1 2.3784(7); C1‐Pd1‐Br1 86.85(8), C1‐Pd1‐Br2 87.63(8), Br1‐Pd1‐S1 87.13(2), Br2‐Pd1‐S1 98.76(2); θ 87.1°. 43, Pd1−C1 1.935(2), Pd1−Br1 2.4213(3), Pd1−Br2 2.4201(3), Pd1−O1 2.113(2); C1‐Pd1‐Br1 88.42(6), C1‐Pd1‐Br2 86.46(6), Br1‐Pd1‐O1 88.86(4), Br2‐Pd1‐O1 96.39(4); θ 88.2°.